Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine + Naltrexone for Alcohol Dependence
NCT01214083Phase 2Completed
- Sponsor
- VA Office of Research & Development
- Start
- Oct 2010
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of acetylcysteine in alcohol dependence (3 arms), sponsored by VA Office of Research & Development. Primary endpoint: Percentage of Heavy Drinking Days at 13 weeks. Started Oct 2010; status: completed.
02
Drugs
acetylcysteine
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on NCT01214083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01214083.